Risk prediction in stable angina pectoris

Although stable angina pectoris often carries a favourable prognosis, it remains important to identify patients with an increased risk of cardiovascular (CV) complications. Many new markers of disease activity and prognosis have been described. We evaluated whether common and easily accessible markers in everyday care provide sufficient prognostic information.

[1]  E. B. Lee,et al.  Too Much Information , 2015 .

[2]  J. Udelson.  T.M.I. (Too much information)? , 2011, Circulation.

[3]  P. Deedwania,et al.  Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. , 2011, The American journal of medicine.

[4]  S. Palfrey.  Daring to practice low-cost medicine in a high-tech era. , 2011, The New England journal of medicine.

[5]  P. Hjemdahl,et al.  Comprar Stress and Cardiovascular Disease | Steptoe, Andrew | 9781848824188 | Springer , 2011 .

[6]  L. Wallentin,et al.  Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[7]  D. Moher,et al.  A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.

[8]  Paul M Ridker,et al.  Inflammation in atherosclerosis: from pathophysiology to practice. , 2009, Journal of the American College of Cardiology.

[9]  M. Pencina,et al.  Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.

[10]  Mats Ericson,et al.  Long‐term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction , 2009, Clinical physiology and functional imaging.

[11]  C. Held,et al.  Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris , 2008, Cardiology.

[12]  C. Vlachopoulos,et al.  Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. , 2007, European urology.

[13]  Suzanne Ogilvy Ochs.  TMI (too much information). , 2007, JAAPA : official journal of the American Academy of Physician Assistants.

[14]  S. Yusuf,et al.  Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk , 2007, Circulation.

[15]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[16]  P. Hjemdahl,et al.  Prognostic implications of renal dysfunction in patients with stable angina pectoris , 2006, Journal of internal medicine.

[17]  Eric Boerwinkle,et al.  An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. , 2006, Archives of internal medicine.

[18]  G. Mancia,et al.  Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology. , 2006, European heart journal.

[19]  C. Held,et al.  Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS) , 2005, Heart.

[20]  J. Camm,et al.  [Guidelines on the management of stable angina pectoris: executive summary]. , 2006, Giornale italiano di cardiologia.

[21]  C. Held,et al.  The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[22]  C. Held,et al.  Differential index, a novel graphical method for measurements of heart rate variability. , 2005, International journal of cardiology.

[23]  K. Alexanderson,et al.  Preface: Evidence based medicine and the Swedish Council on Technology Assessment in Health Care (SBU) , 2004 .

[24]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[25]  P. Whincup,et al.  Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. , 2003, European heart journal.

[26]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2003 .

[27]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[28]  C. Held,et al.  Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris , 2002, Heart.

[29]  C. Held,et al.  Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes. , 2001, Clinical physiology.

[30]  L. Alfredsson,et al.  Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987–95. Results from the National AMI Register in Sweden , 2000, Journal of internal medicine.

[31]  C. Held,et al.  Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS). , 2000, European heart journal.

[32]  P. Hjemdahl,et al.  Psychosocial variables in relation to various risk factors in patients with stable angina pectoris , 2000, Journal of internal medicine.

[33]  C. Held,et al.  Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. , 2000, Atherosclerosis.

[34]  C. Held,et al.  Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]). , 1999, The American journal of cardiology.

[35]  C. Held,et al.  Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. , 1999, European heart journal.

[36]  M. Alderman,et al.  Diabetes and cardiovascular events in hypertensive patients. , 1999, Hypertension.

[37]  J. Blumenthal,et al.  Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. , 1999, Circulation.

[38]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[39]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[40]  C. Held,et al.  Ischaemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls. Gender differences and relationships to catecholamines. , 1998, European heart journal.

[41]  C. Held,et al.  Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS). , 1997, Atherosclerosis.

[42]  P. Hjemdahl,et al.  Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls. , 1997, European heart journal.

[43]  C. Held,et al.  Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm. , 1997, Circulation.

[44]  C. Held,et al.  Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). A comparison with healthy controls , 1997, Journal of internal medicine.

[45]  C. Held,et al.  Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) , 1996, European heart journal.

[46]  Z. Freeman.  Stress and cardiovascular disease , 1988, The Medical journal of Australia.